Logo     Print Page  Close Window


News, Events & Presentations


Press Releases | Events Calendar | Presentations

Keyword Search
 
2019 | 2018 | 2017 | 2016
DateTitle 
05/30/19Fibrocell to Present at BIO International Convention 2019Printer Friendly Version
05/29/19Fibrocell Receives FDA Regenerative Medicine Advanced Therapy Designation for FCX-007 Gene Therapy for the Treatment of RDEBPrinter Friendly Version
05/15/19Fibrocell Reports First Quarter 2019 Financial Results and Recent Operational HighlightsPrinter Friendly Version
05/09/19Fibrocell to Host Conference Call and Webcast on Wednesday, May 15, 2019 to Discuss First Quarter 2019 Financial Results and Recent Operational HighlightsPrinter Friendly Version
04/15/19Fibrocell Announces Collaboration with Castle Creek Pharmaceuticals to Develop and Commercialize FCX-007 Gene TherapyPrinter Friendly Version
04/03/19Fibrocell Announces Board Member Christine St.Clare Honored by National Association of Corporate DirectorsPrinter Friendly Version
03/27/19Fibrocell Announces Positive Feedback from Type B End-of-Phase 2 Meeting with FDA on Phase 3 Clinical Trial Design for FCX-007Printer Friendly Version
03/20/19Fibrocell to Host Conference Call & Webcast for Full Year 2018 Financial Results and Recent Highlights on March 27, 2019Printer Friendly Version
02/06/19Fibrocell to Present at 21st Annual BIO CEO & Investor ConferencePrinter Friendly Version
01/16/19Fibrocell to Present at Phacilitate Leaders World 2019Printer Friendly Version